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Aldosterone and mineralocorticoid receptors: Orphan ques- receptors; their closest relatives are receptors for gluco-
tions. Classically, mineralocorticoid receptors (MR) are acti- corticoids, progestins, and androgens (GR, PR, and AR).
vated by aldosterone to promote unidirectional transepithelial STRO receptors are intracellular and operate (STR) assodium transport. Activation of MR in nonepithelial tissues has
ligand-activated transcription factors to regulate genebeen shown to elevate blood pressure (central nervous system;
expression. Such receptors have a domain structure, withCNS) and to cause hypertrophy and fibrosis (heart). For both
epithelial and nonepithelial tissues, there remain a variety of the highest degree of receptor identity ($90% for MR,
questions regarding MR which are not only unanswered but GR, PR, and AR) in the DNA-binding domain (DBD)
also essentially not addressed. Seven such questions include: and substantial homology ($50% for MR, GR, PR, and(1) how the physiologic glucocorticoids (cortisol and corticoste-
AR) in the ligand-binding domain. Orphan receptorsrone) can mimic aldosterone action in epithelial MR, but act as
may have no ligands or as yet undiscovered ligands: weantagonists in the heart and AV3V region; (2) how salt facilitates
the nonepithelial, pathophysiologic effects of aldosterone; (3) knew a lot about opiate receptors before the discovery
how aldosterone activates unprotected AV3V MR in the face of the endogenous opioid peptides.
of orders of magnitude higher circulating glucocorticoid con-
The human MR (hMR) is a 984 amino acid protein,centrations; (4) how unprotected nonepithelial MR act as “al-
for which the cDNA was cloned and sequenced by Arrizaways occupied” receptors in guinea pigs and other species; (5)
how, when 11b hydroxysteroid dehydrogenase type 2 is active, et al over a decade ago [1]. In this landmark study two
epithelial MR occupied by physiologic glucocorticoids appear of the central paradoxes of MR were addressed, recapitu-
transcriptionally inactive; (6) how aldosterone activates epithe- lating previous studies in rat tissue extracts [2]. First,
lial MR in the face of approximately 103-fold higher glucocorti-
when rat tissue extracts were probed with cDNA forcoid levels, plasma binding and 11b hydroxysteroid dehydroge-
hMR, receptor expression was found in kidney and gutnase type 2 activity notwithstanding; and (7) how aldosterone
produces changes in urinary [K1] before [Na1]. as anticipated, but at much higher levels in the hippocam-
pus, clearly a nonepithelial tissue. Secondly, when re-
combinant hMR are expressed in COS cells [1], or tissue
Seven is a magic number. We have seven days of the preparations from adrenalectomized rats [2, 3] or guinea
week and seven deadly sins; Europe is full of magic pigs [3] used as a receptor source, a challenging pattern
groves, from Sevenoaks to Sette Quercia. The Bible tells of affinity for corticosteroids is seen: MR bind aldoste-
of seven lean years and seven fat years. Ingmar Bergman rone and cortisol with indistinguishable, high affinity,
has the seventh seal, the Americans seven brides for and corticosterone with a slightly higher affinity. The
seven brothers, the musical scale seven notes, in Arabic first question raised by these studies is that of the physio-
from gam to ut. One seventh is 0.142857, two sevenths logical role(s) of nonepithelial MR in tissues such as the
0.285714, three sevenths 0.428571, and so on. If you sailed CNS and heart; the second is how aldosterone can ever
the seven seas, you may meet the seven sisters and be occupy MR in epithelia, where it clearly can and does act,
in seventh heaven. Seven wonders of the world, seven given the equivalent or higher affinity of the physiologic
pillars of wisdom, seven dwarfs. glucocorticoids for such receptors, and their much higher
There are a number of points that need to be made circulating concentrations.
as background for a discussion of the seven questions In terms of the second of these questions, the answer
posed. Mineralocorticoid receptors (MR) are members of appears to lie in the operation in epithelial aldosterone
a superfamily of steroid/thyroid/retinoid/orphan (STRO) target tissues of the enzyme 11b hydroxysteroid dehy-
drogenase type 2 (11bHSD2). The enzyme was simulta-
neously cloned from sheep and human cDNA libraries;Key words: glucocorticoids, 11b hydroxysteroid dehydrogenase, non-
epithelial aldosterone actions, STRO receptors. perhaps counterintuitively, the sheep studies emanated
from the United States [4] and the human studies fromÓ 2000 by the International Society of Nephrology
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Australia [5]. Its operation as a gatekeeper conferring ther evidence for the lack of selectivity at the nuclear
response-element level, and the pivotal specificity-con-aldosterone specificity on nonselective MR had been
previously proposed on the basis of experimental studies ferring role for 11bHSD2 in epithelia.
In extraepithelial tissues, 11bHSD2 is not coexpressedin rats [6, 7], which, in turn, were based on the syndrome
of apparent mineralocorticoid excess (AME). AME was with MR, which are thus putatively “unprotected” and
overwhelmingly occupied by cortisol/corticosterone infirst described over 20 years ago as a syndrome of severe
juvenile sodium retention and hypertension in the face vivo. In addition, in a variety of experimental studies,
occupancy of such MR by the physiologic glucocorticoidsof normal or suppressed plasma levels of renin and aldo-
sterone [8]; its etiology has subsequently been shown to does not mimic the effects of aldosterone, but antago-
nizes them. Intracerebroventricular infusion of minutereflect loss-of-function mutations in the gene coding for
11bHSD2 [9]. doses of aldosterone (10 ng/h), for example, has been
shown to elevate blood pressure in the rat over a time11bHSD2 functions as a gatekeeper because, unlike
MR, it can discriminate between aldosterone and the course of days or weeks; intracerebroventricular infusion
of corticosterone (20 ng/h) alone has no effect on bloodphysiologic glucocorticoids. For the latter, the enzyme is
operationally unidirectional, converting glucocorticoids to pressure, but when coadministered with aldosterone cor-
ticosterone very substantially blocks its hypertensive ef-their inactive 11-keto congeners, cortisone and 11-dehydro-
corticosterone. Both of the latter have much lower affinity fects [12].
Second, a peripheral infusion of robust doses of aldo-for MR (and GR), and if they do occupy MR act as
antagonists. In the zona glomerulosa of the adrenal sterone (0.75 mg/h) to rats is followed by hypertension,
cardiac hypertrophy, and cardiac fibrosis, which are simi-gland, the enzyme aldosterone synthase (CYP11B2) con-
verts the methyl (CH3) group at carbon 18 of the steroid larly substantially blocked by the coadministration of
corticosterone at a 30-fold excess [13]; administration ofmolecule to an aldehyde (CHO) group, from whence
comes the name aldosterone. In solution, this highly re- even higher doses of corticosterone alone does not cause
hypertension, cardiac fibrosis, or cardiac hypertrophyactive aldehyde group cyclizes with the hydroxyl at car-
bon 11 to form an 11,18 hemiacetal and to make aldoste- [14]. In studies on isolated neonatal rat cardiomyocytes,
a similar distinction between MR occupancy by aldoste-rone not a substrate for 11bHSD2.
Upon this very brief background sketch of MR and rone and corticosterone can be shown, in that aldoste-
rone increases [3H]leucine incorporation into protein,11bHSD2, the seven questions will be put, as follows.
whereas corticosterone does not [15].
There is thus a clear difference between how the physio-
QUESTION 1
logic glucocorticoids act in epithelial MR, as aldosterone
How is it that the physiologic glucocorticoids (cortisol, mimics, and in nonepithelial tissues, where they act as
corticosterone) mimic aldosterone in epithelial antagonists just like spironolactone or RU28318. There
mineralocorticoid receptors, but act as antagonists in is no difference between MR in different tissues in terms
the heart and the AV3V region? of sequence; a one- to two-fraction difference in a fast
protein liquid chromatography (FPLC) elution profileThe syndrome of AME, as noted above, is character-
ized by inappropriate and very marked Na1 retention has been shown for hippocampal and renal MR, consis-
tent with there being an approximately 15K moleculein response to the inability of the loss-of-function mutant
11bHSD2 to metabolize cortisol, and thus exclude it bound to one but not the other receptor [16]. Apart from
this study, which is now over a decade old, there appearfrom renal and colonic MR. As this suggests, cortisol
in epithelial MR acts to mimic aldosterone. When to be no data on the tissue-specific factors that engender
the difference in behavior of epithelial and nonepithelial11bHSD2 is blocked by carbenoxolone, the hemisucci-
nate of glycyrrhetinic acid, corticosterone similarly can MR occupied by corticosterone/cortisol. Whether the
same mechanisms obtain in nonepithelial cells and in epi-act as a potent mineralocorticoid in Kagawa bioassays
in the adrenalectomized rat, in the presence of excess thelial cells in which 11bOHSD2 is operant (question 5,
below) to preclude an MR-glucocorticoid complex fromRU486 to exclude the corticosterone from GR [10].
What these Kagawa bioassay studies also show is that transcriptional activity remains to be determined.
GR occupancy in epithelial aldosterone target tissues is
similarly followed by a mineralocorticoid response, in
QUESTION 2
that the highly selective GR agonist RU28362 in the
How does salt facilitate the nonepithelial,presence of carbenoxolone produces an electrolyte re-
pathophysiological effects of aldosterone?sponse equivalent to that of aldosterone. In more recent
studies [11], dexamethasone has been used in A6 cells It has long been known in studies on experimental
hypertension that uninephrectomy and obligate drinkingto induce a classic “mineralocorticoid” response, induc-
tion of sgk synthesis (discussed later in this article), fur- of 0.9% NaCl solution sensitize rats to exogenous miner-
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alocorticoid administration. In their pioneer studies on is shown by the results of studies by Gomez-Sanchez,
Fort, and Thwaites in JR/S (salt-sensitive) rats [20]. Thiscardiac hypertrophy and fibrosis in response to aldoste-
rone, Brilla and Weber showed that although unin- strain of rat responds to a 6% NaCl intake by an increase
in blood pressure over the subsequent days and weeks.ephrectomized rats drinking 0.9% NaCl responded to
peripheral infusion of aldosterone of 0.75 mg/h by devel- If the rats are simultaneously infused intracerebroven-
tricularly with the MR antagonist RU28318, blood pres-oping cardiac hypertrophy and both perivascular and
interstitial fibrosis, those on a restricted sodium intake sure does not rise; if the RU28318 infusion begins during
the period of salt-induced blood pressure rise it is attenu-did not [17]. In both situations, aldosterone may be antic-
ipated to occupy MR to a similar extent, and the equiva- ated, and blood pressure returns toward normal.
There are a number of points to be made from thislent right and left ventricular fibrosis [14, 17] is strong
evidence for a humoral rather than a hemodynamic etiol- study. First, even in the face of a 6% Na1 intake aldoste-
rone levels appear still sufficiently high to occupy at leastogy for the observed effects.
One possible way in which the high Na1 status may some part of the AV3V MR population: evolution has
been much more concerned with increasing aldosteronedetermine the response to aldosterone, to synergize in
producing hypertrophy and fibrosis, is suggested by a re- levels in the face of sodium deficiency or loss than in
suppressing them in the face of a high salt intake. Second,cent report from Gu et al [18]. In these studies, a 4%
increase in ambient [Na1] in vitro (from 146 to 152 mEq/L) unless there are non-11bHSD2 mechanisms for exclud-
ing glucocorticoids, only a tiny proportion of AV3V MRwas followed by very marked changes in various parame-
ters measured in neonatal rat myocardial myoblasts and would seem to need to be occupied by aldosterone to
elevate blood pressure. Third, such a non-11bHSD2vascular smooth muscle cells. Whereas for both cell types
cell diameter increased approximately 9% and cell vol- mechanism for excluding glucocorticoids appears un-
likely, given the ability of corticosterone coinfused intoume approximately 27%, cellular protein content in-
creased by approximately 50%, and the rate of protein the lateral ventricle to block the hypertensinogenic effect
of centrally administered aldosterone. While no answerconcentration as gauged by [3H]leucine incorporation
almost doubled. The conclusion drawn by these authors to this question is immediately obvious, two things would
seem to be the case: (1) that the concept of “spare recep-is that Na1 may thus have a direct effect to induce cellular
hypertrophy in both heart and vasculature; the way in tors” applies, so that only a tiny proportion of AV3V
MR needs be occupied by aldosterone to produce hyper-which such effects may be transduced into cardiac fibro-
sis remains to be explored. tension; and (2) that even to achieve such low levels of
occupancy aldosterone can probably access unprotected
MR only during the nadir(s) of plasma glucocorticoid
QUESTION 3
levels.
How can aldosterone activate unprotected AV3V
mineralocorticoid receptors in the face of
QUESTION 4orders of magnitude higher circulating
glucocorticoid concentrations? How can unprotected nonepithelial mineralocorticoid
receptors act as “always occupied” receptors, inWhereas in epithelia MR and 11bHSD2 are closely
guinea pigs and other species?colocalized—in kidney collecting tubule, colon, salivary
gland duct cells, and sweat gland—the enzyme distribu- As noted above, unprotected MR are prima facie con-
stitutively occupied by physiological glucocorticoids intion in the brain is quite different. In the rat brain, on
in situ hybridization, 11bHSD2 appears to be expressed the CNS and elsewhere, given their high affinity and the
high circulating glucocorticoid levels. Even if for speciesin the commissural position of the nucleus tractus solita-
rius and the ventrolateral ventromedial hypothalamus. like humans or the rat occupancy may fall to levels be-
tween 90 and 95% at nadir glucocorticoid levels, suchIn addition, scattered labeled cells are found in the me-
dial vestibular nucleus [19]. This distribution is quite would not appear to be the case in the guinea pig, for
the following reasons. The guinea pig has long beendistinct from that of 11bHSD1 in the brain, and also
from that of MR; the latter are most heavily concentrated known to be corticoresistant, despite very high circulat-
ing levels of cortisol and modest levels of corticosteroid-in the hippocampal and septal regions, and are also found
in the AV3V region where they influence blood pressure binding protein (CBG), so that in contrast with other
species only approximately 30% of cortisol is transcortinregulation.
In both of these areas, unprotected MR are presum- bound. Underlying this glucocorticoid resistance appear
to be very low-affinity GR [21], with a frequency ofably overwhelmingly occupied by the physiological glu-
cocorticoids, given their much higher circulating concen- mutation in the ligand-binding domain of the GR twice
that predicted from mutation frequency elsewhere intrations. That such AV3V MR can be occupied, despite
this concentration difference, by circulating aldosterone the molecule [22]. Despite the very high total and free
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cortisol levels, the affinity of guinea pig MR for aldoste- of MR might be one thousandth of those in the cell as
a whole. Under such circumstances, 11bHSD2 would berone, corticosterone, and cortisol is identical to that in
the rat—in kidney, colon, heart, and hippocampus [3]. acting as a physical “protector” of epithelial MR, as well
as a one-way cortisol sink.The implication for unprotected MR of this study is
profound. Rather than the dynamic range of unprotected That such a mechanism does not in fact operate is
suggested by a series of in vivo studies in which adrenal-MR occupancy by glucocorticoids being in the range of
90 to 99%, it is in the range of 99 to 99.9%, to a first ectomized rats were injected in vivo with [3H]aldoster-
one, alone or together with 1-, 3-, 10- to 100-fold nonradio-approximation. The driving mutation in guinea pigs ap-
pears to be an Ala24Pro substitution in the otherwise active aldosterone or corticosterone, and specific binding
determined in kidney, colon, heart, and hippocampusinvariant sequence of adrenocorticotropic hormone
(ACTH), leading to a superagonist ACTH [23] and thus [25]. As noted above, corticosterone has approximately
three times the affinity of aldosterone for MR, and muchpresumably favoring the continuing evolution of low-
affinity/low-activity GR. In contrast, the MR appears higher affinity for plasma CBG (transcortin), such that
whereas approximately 50% of plasma aldosterone ispristine, and to have retained the high affinity found in
species with much lower circulating levels of total and protein bound (to albumin) $95% of plasma corticoste-
rone is bound to CBG and albumin. If there are nofree GR.
We are unused to the concept of an “always occupied” barriers to cellular or intracellular access of plasma-free
steroid to MR, then nonradioactive aldosterone wouldreceptor, although intuitively there is nothing particular
about a constitutively inhibited system that responds to be predicted to be approximately three times as potent
as corticosterone in competing for MR.lifting of that inhibition over a relatively small albeit
linear dynamic range. A second possibility is that of the In the heart this proved to be the case, but not in the
three other tissues examined. In hippocampus, cortico-formation of MR:GR heterodimers, of varying transcrip-
tional efficiency compared with homodimers. Finally, sterone proved to be approximately twice as good a
competitor as nonradioactive aldosterone, due to theMR have equivalent high affinity not only for corticoste-
rone, cortisol, and aldosterone, but also for progesterone much higher reflection coefficient of the blood brain bar-
rier for aldosterone. In the kidney and colon, in contrast[24]. There are occasions, in the luteal phase, in preg-
nancy, and in the fetus, when circulating levels of proges- with both nonepithelial tissues, 11bHSD2 operated to
lower the observed ability of corticosterone to competeterone are sufficiently high prima facie to compete with
cortisol/corticosterone for binding to unprotected MR, for [3H]aldosterone binding to MR. In both tissues, non-
radioactive aldosterone was 20 to 50 times as potent ofin the CNS and elsewhere.
competitor as corticosterone; that is, on average, 11bHSD2
adds an additional order of magnitude of steroid selectiv-
QUESTION 5
ity to MR, equivalent to the level of specificity conferred
How is it that when 11bHSD2 is active epithelial by the preferential binding of corticosterone by CBG,
mineralocorticoid receptors occupied by and very much in line with the approximately 10% “leak”
glucocorticoids appear to be transcriptionally inactive? predicted previously in this article. The plasma total con-
centrations of cortisol are characteristically approxi-At a first approximation, there are approximately
10,000 hMR per principal cell in the collecting tubule, mately three orders of magnitude higher than those of
aldosterone, so even with a tenfold advantage due towith an affinity for aldosterone and cortisol of approxi-
mately 1 nmol/L. In contrast, the numbers of h11bHSD2 CBG, and another tenfold advantage due to 11bHSD2,
most MR will be largely occupied by cortisol even inmolecules are much higher, of the order of 3 to 4 million
per cell; their “affinity” for cortisol is, however, much epithelial tissues. How is it that under such conditions
we do not retain sodium and become hypertensive, aslower than that of the receptor, as denoted by a Km of
40 to 50 nmol/L. If access to both receptor and enzyme happens when cortisol occupancy of MR follows inhibi-
tion or congenital absence of 11bHSD2?is competitive, then approximately 10% of cortisol mole-
cules to be bound within the cell will be to MR and One possible answer may lie in the cosubstrate for
11bHSD2, NAD. If in the presence of NADH MR·corti-approximately 90% to 11bHSD2; that is, there will be a
“leak” past the protective enzyme of approximately 10%. sol complexes were transcriptionally inactive in epithelial
tissues (as appears normally to be the case in nonepithe-This need not be the case if there are differences in
intracellular access between MR and 11bHSD2 in terms lial tissues), then the apparent paradox would be ex-
plained. If this proves to be the case (and the crucialof their availability to cortisol. If, for example, the 300-
to 400-fold excess of 11bHSD2 molecules were arranged importance of redox state for GR-mediated transactiva-
tion has recently been shown in a series of elegant stud-as a multimeric protective lattice around MR, particu-
larly if such a lattice were several layers deep, the levels ies) [26, 27], then 11bHSD2 will have two interlinked,
crucial roles: to metabolize cortisol to the low affinity,of free cortisol in the immediate physical environment
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antagonist product cortisone and to provide a particular rone-induced proteins cloned by Pearce et al from A6
intracellular milieu in which cortisol, which does bind cells, and the nature of these (and other possible induced
MR, is transcriptionally inactive (presumably in contrast proteins not identified to date) is at present unknown.
with aldosterone bound to MR). Whether this proves to There is some evidence from in vivo studies that one
be the case is susceptible to experimental determination: of this group may provide a mechanism for aldosterone-
if so, such a redox-dependent activation/inactivation sta- induced K1 flux, with a time course of action discernibly
tus may also be of relevance in nonepithelial tissues, faster than that of sgk to increase the open probability of
allowing cortisol·GR complexes to act as sensors of intra- ENaC. In recent Kagawa bioassay studies on the urinary
cellular redox status. response of adrenalectomized rats to aldosterone (un-
published data), we measured urinary [Na1] and [K1]
before steroid administration and at 30-minute intervalsQUESTION 6
thereafter. In such studies, urinary [Na1] did not change
How can aldosterone activate epithelial MR, in the over the first hour after aldosterone, whereas urinary
face of approximately 103-fold higher glucocorticoid [K1] rose progressively to be substantially (approxi-
levels, plasma binding and 11bHSD2 mately 60%) and significantly higher in the 130- to 160-
activity notwithstanding?
minute collection than control. A specific effect of aldo-
This is the other side of the coin to the previous ques- sterone on [K1] excretion is not perhaps unexpected,
tion, which addressed how MR·cortisol complexes do given how potent quite small elevations in ambient
not appear to be transcriptionally active. One possibility plasma [K1] are in terms of increasing aldosterone secre-
whereby aldosterone may be able to access epithelial tion rate [31]. The mechanism(s) underlying this effect
MR is in the nadir of plasma GR concentrations, when of aldosterone on [K1] excretion at a molecular level
experimentally it has been shown by sufficiently frequent remains to be explored.
sampling [28] that plasma corticosterone in rats may In summary, although there have been considerable
fall below detection limits. We are comfortable with the recent advances in our understanding of how aldosterone
concept of pulsatile or episodic secretion of hormones acts in [Na1] transporting epithelia, a range of questions
[for example, luteinizing hormone–releasing hormone remain to be answered in both epithelial and nonepithe-
(LHRH)]; we are less used to the possibility of episodic lial tissue about roles for aldosterone, and more generally
action, when levels of a potential competitor for receptor for MR. These questions may be answered without being
binding fall episodically below a threshold level. directly addressed, as has on a number of occasions
One possible additional outcome of such a system is
proved to be the case in other areas in which molecular
aldosterone·MR-mediated responses to stress. When rats
biological techniques have been applied in endocrinology.were stressed in the incremental phase of ACTH/cortico-
On the other hand, some of them are susceptible to beingsterone secretion, the amplitude of the corticosterone
directly addressed; and if this paper provides a stimuluspulse increased, but the length of the nadir between
for such inquiry, it will have served its purpose well.the exaggerated pulse and that subsequent lengthened
considerably. If aldosterone can occupy MR only at the Reprint requests to Dr. John W. Funder, Baker Medical Research
Institute, P.O. Box 6492, St. Kilda Road Central, Melbourne 8008,nadir of the interpulse interval, stress may very much
Victoria, Australia.potentiate MR·aldosterone action in epithelial and/or
E-mail: sue.smith@baker.edu.au
nonepithelial tissues, by considerably enlarging the win-
dow of opportunity for receptor occupancy.
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